Rajan Swami

Rajan Swami


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
NKNavjeet Kaur
Navjeet Kaur
PPPankaj Popli
Pankaj Popli
NTNeha Tiwary
Neha Tiwary
RSRajan Swami
Rajan Swami

7 August 2017 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
SJSanyog Jain
Sanyog Jain
BHB. Heeralal
B. Heeralal
RSRajan Swami
Rajan Swami
NSNitin K. Swarnakar
Nitin K. Swarnakar
VKVarun Kushwah
Varun Kushwah

8 April 2024 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
PCPidugu Shivaji Ashok Chakravarthy
Pidugu Shivaji Ashok Chakravarthy
PPPankaj Popli
Pankaj Popli
RCRanadheer Reddy Challa
Ranadheer Reddy Challa
BVBhaskar Vallamkonda
Bhaskar Vallamkonda
ISInderbir Singh
Inderbir Singh
RSRajan Swami
Rajan Swami

7 March 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
RSRajan Swami
Rajan Swami
PPPankaj Popli
Pankaj Popli
KSKomal Sal
Komal Sal
RCRanadheer Reddy Challa
Ranadheer Reddy Challa
BVBhaskar Vallamkonda
Bhaskar Vallamkonda
CDChander Parkash Dora
Chander Parkash Dora

30 January 2024 in Nanomedicine
Verified
Journal Article
Closed access
RSRajan Swami
Rajan Swami
SVSahil Vij
Sahil Vij
SSShubham Sharma
Shubham Sharma
Cancer cells need as much as 40-times more sugar than their normal cell counterparts. This sugar demand is attained by the excessive expression of inimitable transporters on the surface of cancer c...

29 March 2025 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
SUSaumya Upadhyay
Saumya Upadhyay
RSRajan Swami
Rajan Swami
SSShweta Shrivastava
Shweta Shrivastava
MJManish Kumar Jeengar
Manish Kumar Jeengar
Inflammation is a universal response of mammalian tissue to harm, comprising reactions to injuries, pathogens, and foreign particles. Chronic inflammation, often present in allergies and autoimmune disorders, poses significant risks, potentially leading to conditions such as rheumatoid arthritis, Alzheimer's disease, asthma, and inflammatory bowel disease. It can also be a common precursor to cancer. However, Contemporary therapies like NSAIDs and corticosteroids often provide incomplete relief from chronic inflammation and carry significant side effects, underscoring the need for exploring traditional and plant-based medicines for new, effective treatments. As such, there is a growing demand for natural bioactive substances for health maintenance and disease risk reduction. Traditional and plant-based medicines, long-used in managing inflammation and other disorders, hold promise for the discovery of bioactive lead compounds and subsequent drug development for treating inflammatory disorders. This review encompasses an extensive study of the anti-inflammatory potential of selected traditional Indian herbal medicines and the associated pharmacological mechanisms of action. The inflammatory process often entails the activation of transcription factors, induction of various signaling cascades, gene expression, activation of inflammatory enzymes, and release of pro-inflammatory cytokines in inflammatory or immune cells. Detailed exploration of active components in traditional herbal medicines such as the Neem (Azadirachta indica), Salai guggul (Boswellia serrata), Green tea (Camellia sinensis), Saffron (Crocus sativus), Turmeric (Curcuma longa), Mangosteen (Garcinia mangostana), Indian mulberry (Morinda citrifolia), Black cumin (Nigella sativa), Ashwagandha (Withania somnifera), and Ginger (Zingiber officinale) reveals their potential anti-inflammatory properties. The in-depth study of these plants provides insight into their potential applications in managing inflammatory disorders. Further research and development are necessary to substantiate these findings and translate them into clinically effective therapeutics.